| Prof Paul Myles CIB |
| Prof Tomas Corcoran CIA |
The project received $4.3 million, the highest amount awarded in the recent MRFF neurological disorders grant initiative announced by the Australian Federal Minister for Health Greg Hunt on 25 June.
It is estimated that nearly half of breast cancer patients experience some chronic pain after surgery. The five year LOLIPOP (Long-term Outcomes of Lidocaine Infusions for persistent Postoperative Pain) study will administer lidocaine intravenously to patients during and up to 24 hours after breast cancer surgery.



